Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
https://www.businessinsider.com/retro-biotech-testing-higher-doses-of-rtr-242-alzheimers-drug-2026-8
Sam Altman's longevity company is testing an extra-strength Alzheimer's drug after disappointing trial results
The Sam Altman-backed longevity biotech company is upping the dose of its experimental Alzheimer's drug in clinical trials.
Ähnliche Seiten
FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results | The Independent
https://www.independent.co.uk/news/health/new-hepatitis-b-drug-fda-b2985053.html
Layoffs at Sam Altman's $2.5 billion startup, as company struggles to show how its key 'Eye technology' can generate revenue - The Times of India
https://timesofindia.indiatimes.com/technology/tech-news/layoffs-at-sam-altmans-2-5-billion-startup-as-company-struggles-to-show-how-its-key-eye-technology-can-generate-revenue/articleshow/131606618.cms
Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company—finding its next blockbuster drug is proving difficult | Fortune
https://fortune.com/2026/08/06/weight-loss-drug-wegovy-novo-nordisk-europe-most-valuable-company-blockbuster-drug/
'Blockbuster' one-shot low back pain drug in the home stretch of final test
https://newatlas.com/chronic-pain/promising-one-shot-low-back-pain-drug/White House is upset with Sam Altman's OpenAI and reason is appointment of the executive who Pentagon AI chief Emil Michael called AI world's 'supreme village idiot' - The Times of India
https://timesofindia.indiatimes.com/technology/tech-news/white-house-is-upset-with-sam-altmans-openai-and-reason-is-appointment-of-the-executive-who-pentagon-ai-chief-emil-michael-called-ai-worlds-supreme-village-idiot/articleshow/133141897.cms